Leading Firm Cadila Pharmaceuticals Launches Vaccine For Seasonal flu

Cadila Pharmaceuticals said it has introduced an immunization to prevent flu, a repetitive and far and wide viral infection. The medication firm has presented quadrivalent Cadiflu Tetra immunization, endorsed by the DCGI (Drugs Controller General...

Ayush-ICMR Health Research Center Launched at AIIMS

Union Minister of Health and Family Welfare Dr Mansukh Mandaviya launched the Ayush-ICMR Advanced Centre for Integrated Health Research in AIIMS and announced other mega joint initiatives between the Health Ministry and the Ministry of Ayush.

Rare Disease Action Plan 2024 Launched, NIHCR Welcomes

The UK Government's Rare Disease Action Plan 2024 has been published, detailing what the NIHR, DHSC and others have done over the past year to better meet the needs of patients with rare diseases.

Indira IVF and BD SurePath Partner for Cervical Cancer Screening in India

In a major move to improve the accuracy and accessibility of breast cancer screening in India, Indira IVF has partnered with BD SurePath.

FDA Approves J&J's Rybrevant Combo for NSCLC with EGFR Exon 20 Insertions

Johnson and Johnson announced that following a priority review, the U.S. Food and Drug Administration (FDA) has approved Rybrevant (amivantamab-vmjw) in combination with chemotherapy (carboplatin-pemetrexed) for the first-line treatment of patients w

Global Healthcare Brands Eye India Opportunities - Chairman, Aaron Capital, Inc. USA

The current impediments to bilateral relations include tariff and non-tariff barriers, complex custom clearance procedures, IPR and data localization issues” - David Sanford Wolfe, Chairman, Aaron Capital, Inc USA.

Indian API Industry: Make in India & PLI to Limit China Imports

The Indian active pharmaceutical ingredient (API) industry believes that the Make in India initiative and the PLI (production-linked incentive) scheme will help limit imports from China.

CAHOCON 2024: Kolkata Global Healthcare Conclave - April 6 & 7

To revolutionize the healthcare landscape, the 8th Edition of CAHOCON 2024 is set to unfold between April 6 and 7 at the Biswa Bangla Convention Centre in Kolkata with a theme that resonates globally.

India To Become Major Exporter of Bulk Drugs: Health Minister

India has continued on toward turned into a significant exporter of bulk drugs and medical devices, Health Minister, Mansukh Mandaviya said. As per him, India dealt with plans and plans to de-risk its store network from worldwide ideas and...

Ginkgo Bioworks Buys Reverie Labs To Advance AI-driven Drug discovery

Ginkgo Bioworks, a startup developing the leading platform for cell programming and biosecurity, has announced the purchase of key assets from Reverie Labs, which created and applied AI/ML techniques to expedite drug discovery. Ginkgo has...

© 2025 India Pharma Outlook. All Rights Reserved.